Assertio's Participation in the iAccess Alpha Conference
Assertio Holdings, Inc. is gearing up for an important presentation at the iAccess Alpha Best Ideas Spring Investment Conference. This virtual event will take place from March 25-26. It offers a prime opportunity for investors and industry stakeholders to gain insights into Assertio's strategic direction, innovative products, and growth potential.
Presentation Details
Brendan O’Grady, the CEO of Assertio, will take the stage on March 25 at 1:30 PM Eastern Time. This presentation aims to shed light on the company’s recent advancements, focusing on how its offerings align with market needs. The virtual format allows attendees from various regions to participate easily.
Engagement Opportunities for Investors
During the conference, investors will have the chance to engage directly with the management team through 1x1 meetings set for March 26. This personal interaction will provide valuable insights into the company’s future objectives and operating strategies. Interested conference participants can coordinate these meetings through their conference representative or directly through Assertio's investor relations.
About Assertio Holdings
Assertio is a dynamic pharmaceutical company committed to addressing patients' diverse needs through its specialized and differentiated product offerings. Their primary focus is on therapeutic areas including oncology, neurology, and pain management. By concentrating on these critical fields, Assertio strives to improve patient outcomes and quality of life.
How to Connect with Assertio
To learn more about Assertio and its innovative products, investors and interested parties can visit Assertio's website. Furthermore, for direct inquiries or information regarding the conference, contact Matt Kreps, Managing Director at Darrow Associates, via his email for a more personalized communication experience.
Frequently Asked Questions
What is the iAccess Alpha Best Ideas Spring Investment Conference?
The iAccess Alpha Best Ideas Spring Investment Conference is a virtual event designed to connect investors with executives from promising companies like Assertio, offering insights into strategies and market positions.
When will Assertio's presentation take place?
Assertio’s presentation is scheduled for March 25 at 1:30 PM Eastern Time, providing attendees the opportunity to learn about the company’s focus and growth strategies.
How can investors arrange 1x1 meetings with Assertio’s management?
Investors can coordinate 1x1 meetings with Assertio's management through their conference representative or by reaching out directly to Assertio's investor relations.
What therapeutic areas does Assertio focus on?
Assertio primarily focuses on oncology, neurology, and pain management, aiming to develop products that meet significant patient needs in these areas.
Where can I find more information about Assertio?
For additional information, stakeholders can visit Assertio's official website, which offers insights into its product offerings and company news.
